Often the villain, fructose may play hero’s role in muscular dystrophy treatment – Medical Xpress

March 3, 2017

A substance widely known as a villain for its role in causing obesity-related health problems has emerged as a possible hero in the fight against a debilitating genetic disorder.

Research suggests that fructose, a sugar found in honey, fruits and vegetables, makes a type of molecular treatment for Duchenne muscular dystrophy more effective.

Progressive muscle degeneration and weakness characterize Duchenne muscular dystrophy, which is caused by the absence of a protein, dystrophin, that helps keep muscles intact.

Symptoms usually appear around age 4, first affecting the shoulders, upper arms, hips and thighs. Patients have a hard time rising from the floor, climbing stairs, keeping their balance and raising their arms.

Ultimately, they require use of a wheelchair, and most die in their 30s when their cardiac and respiratory systems fail. Duchenne primarily affects males, and about one boy in 3,500 will be born with it.

Hong Moulton of the Oregon State University College of Veterinary Medicine was part of an international collaboration that looked at fructose's ability to enhance the uptake and activity of antisense oligonucleotides, or AOs. Therapy with those molecules has been shown to restore some production of dystrophin, but efficiently delivering the molecules to the muscle cells has been a challenge.

This research, which addressed the delivery challenge, involved dystrophin-deficient rodents known as mdx mice. Findings suggest that when fructose is administered along with a type of AO known as a phosphorodiamidate morpholino oligomer, or PMO, the AO gets into muscle cells four times better. This results in more production of dystrophin and better recovery of some muscle use. Fructose also enhanced delivery of a PMO conjugated to a cell-penetrating peptide, a molecule known as a PPMO.

"We don't yet understand the mechanism," Moulton said. "Maybe it's that the fructose is an energy source that enhances uptake, because uptake in muscle cells requires energy. But right now the mechanism is unknown."

Compared with other delivery technologies, fructose has low toxicity, making it both safe and efficient. No weight gain or any abnormal behavior was observed in the mice in the study.

The findings by Moulton, HaiFang Yin's research group at China's Tianjin Medical University and collaborators at Singapore's Agency for Science Technology and Research were recently published in the journal Molecular Therapy Nucleic Acids. The results follow the Food and Drug Administration's 2016 approval of Eteplirsen the first drug approved for Duchenne muscular dystrophy in the United States.

Eteplirsen is also the first PMO to win FDA approval, as well as the first oligonucleotide that modulates gene splicing which is how PMOs can promote the production of dystrophin.

Soon the delivery-enhanced PPMO, a drug type pioneered by Moulton, will enter clinical trials for Duchenne muscular dystrophy.

"Currently the approved drug has minimal efficacy, and the underlying problem is the morpholino by itself has very limited muscle uptake," Moulton said. "If you can get more material into the muscle, then you can have more dystrophin produced. The fructose approach we studied can do that."

Explore further: Emflaza approved for duchenne muscular dystrophy

More information: Limin Cao et al. Fructose Promotes Uptake and Activity of Oligonucleotides With Different Chemistries in a Context-dependent Manner in mdx Mice, Molecular Therapy - Nucleic Acids (2016). DOI: 10.1038/mtna.2016.46

(HealthDay) Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in people five years and older, the agency said Thursday in a news release.

Duchenne muscular dystrophy is a chronic disease causing severe muscle degeneration that is ultimately fatal. As the disease progresses, muscle precursor cells lose the ability to create new musclar tissue, leading to faster ...

A new paper, co-written by faculty at Binghamton University, State University of New York, increases the understanding of Duchenne muscular dystrophy (DMD)one of the most common lethal genetic disordersand points to ...

A new study from The Ottawa Hospital and the University of Ottawa is poised to completely change our understanding of Duchenne muscular dystrophy and pave the way for far more effective treatments.

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Scientists are using "gene scissors" to cut off the code of a defective gene that results in progressively weaker muscles and death in Duchenne muscular dystrophy and replace it with a synthetic code they hope will one day ...

A type of drug used to treat weak bones is associated with an increased risk of 'micro-cracks' in bone, according to new research.

A molecular key to aging of the blood and immune system has been discovered in new research conducted at UC San Francisco, raising hope that it may be possible to find a way to slow or reverse the growing risk for aging-associated ...

Two weeks of voluntary wheel running induces higher expression of irisina fat-burning hormone that is released during exercisein bone tissue in mice. In addition, systemic administration of irisin increased bone formation ...

A substance widely known as a villain for its role in causing obesity-related health problems has emerged as a possible hero in the fight against a debilitating genetic disorder.

Ionizing radiation incidentsnuclear war, nuclear accidents or terrorist dirty bombs, for examplecan cause mass fatalities. Since resources for medical countermeasures are limited, it's critically important to swiftly ...

(Medical Xpress)A team of researchers from China and Japan has found that BHPF, a replacement chemical for BPA in plastics, can also cause estrogen-related problems in mice. In their paper published in the journal Nature ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Go here to see the original:
Often the villain, fructose may play hero's role in muscular dystrophy treatment - Medical Xpress